Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information, inc...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2020-11-01
Series:	Molecular Oncology
Assuntos:	chromosomal instability genomic profiling newly diagnosed glioblastoma NTRK fusion translational relevance tumor mutational burden
Acceso en liña:	https://doi.org/10.1002/1878-0261.12790
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!